| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
President And CSO | President And CSO | Chief Scientific Officer
1 company
Suri Anish is a President And CSO at Cue Biopharma, Inc.. Recent SEC Form 4 filings include 2 buys and 6 sells.
Estimated insider holdings value: $4.7M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Aug 25, 2023 | CUE Cue Biopharma, Inc. | President And CSO | Buy | 4,000 | $2.76 | $11,040.00 | +3.0% | -12.5% | -72.4% | |
| Nov 15, 2021 | CUE Cue Biopharma, Inc. | President And CSO | Sale+OE | 8,000 | $18.05 | $144,400.00 | -7.8% | -62.5% | -78.8% | |
| Nov 11, 2021 | CUE Cue Biopharma, Inc. | President And CSO | Sale+OE | 20,000 | $15.07 | $301,354.00 | -17.5% | -54.2% | -79.2% | |
| Sep 23, 2021 | CUE Cue Biopharma, Inc. | President And CSO | Sale+OE | 20,000 | $15.23 | $304,646.00 | -21.1% | -21.4% | -82.2% | |
| Aug 5, 2020 | CUE Cue Biopharma, Inc. | President And CSO | Sale+OE | 800 | $20.01 | $16,008.00 | -2.3% | - | - | |
| Aug 4, 2020 | CUE Cue Biopharma, Inc. | President And CSO | Sale+OE | 6,200 | $20.02 | $124,114.00 | -8.2% | - | - | |
| Dec 21, 2018 | CUE Cue Biopharma, Inc. | Chief Scientific Officer | Buy | 2,000 | $4.37 | $8,740.00 | New | - | - |